Harmony Biosciences director granted stock options
Harmony Biosciences Holdings, Inc. reported that director Linda M. Szyper received a grant of stock options covering 21,872 shares of common stock at an exercise price of $30.76 per share.
Rhea-AI Filing Summary
Harmony Biosciences Holdings, Inc. reported that director Linda M. Szyper received a grant of stock options covering 21,872 shares of common stock at an exercise price of $30.76 per share. These options expire on May 14, 2036 and represent compensation rather than an open‑market purchase.
The option vests in full on the earlier of May 14, 2027 or the date of the next annual meeting following the grant, as long as Szyper continues in service through that date. Following this award, she holds 21,872 derivative securities directly tied to Harmony Biosciences common stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 21,872 shares
Grant/Award
1 txn
Insider
Szyper Linda M
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option | 21,872 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option — 21,872 contracts (Direct)
Footnotes (1)
- F1. The stock option shall vest in full on the earlier to occur of (i) May 14, 2027 and (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date.
Key Figures
Option grant size: 21,872 options
Exercise price: $30.76 per share
Expiration date: May 14, 2036
+3 more
6 metrics
Option grant size
21,872 options
Stock option award to director Linda M. Szyper
Exercise price
$30.76 per share
Stock option exercise price
Expiration date
May 14, 2036
Option expiration for the grant
Underlying shares
21,872 shares
Common stock underlying the options
Post-grant derivative holdings
21,872 derivatives
Total derivative securities held after grant
Vesting date reference
May 14, 2027
Latest possible full vesting date, subject to earlier annual meeting
Key Terms
Stock Option, Common Stock, exercise price, vest in full, +1 more
5 terms
Stock Option financial
"security_title: "Stock Option""
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
Common Stock financial
"underlying_security_title: "Common Stock""
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
exercise price financial
"conversion_or_exercise_price: "30.7600""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vest in full financial
"The stock option shall vest in full on the earlier to occur"
annual meeting financial
"the date of the next annual meeting following the grant date"
A company's annual meeting is a yearly gathering where owners (shareholders) and the board review performance, ask questions, and vote on key matters like electing directors, approving auditor choices, and sometimes setting pay or dividend policies. For investors it matters because decisions made and votes cast can change who runs the company, influence strategy and payouts, and affect the value or direction of their investment—similar to a homeowners’ meeting where rules and leaders that shape your property’s value are decided.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Harmony Biosciences (HRMY) disclose for Linda M. Szyper?
Harmony Biosciences disclosed that director Linda M. Szyper received a grant of stock options for 21,872 shares. The award is compensation-based, not an open-market purchase, and gives her the right to buy common stock at a fixed exercise price.
What is the exercise price and expiration date of Linda Szyper’s Harmony Biosciences (HRMY) options?
Linda Szyper’s options have an exercise price of $30.76 per share and expire on May 14, 2036. She can choose to exercise any vested options before that expiration, subject to the plan’s standard terms and conditions.
When do Linda Szyper’s Harmony Biosciences (HRMY) stock options vest?
The options vest in full on the earlier of May 14, 2027, or the date of the next annual meeting following the grant. Vesting requires that Linda Szyper continue her service with the company through the applicable vesting date.
AI-generated analysis. How Rhea-AI works. Not financial advice.
